- Home
- PTGX vs IRT Comparison
PTGX vs IRT Comparison
Compare PTGX & IRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- IRT
- Stock Information
- Founded
- PTGX 2006
- IRT 2009
- Country
- PTGX United States
- IRT United States
- Employees
- PTGX N/A
- IRT N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- IRT Real Estate Investment Trusts
- Sector
- PTGX Health Care
- IRT Real Estate
- Exchange
- PTGX Nasdaq
- IRT Nasdaq
- Market Cap
- PTGX 5.0B
- IRT 3.9B
- IPO Year
- PTGX 2016
- IRT 2013
- Fundamental
- Price
- PTGX $84.83
- IRT $16.64
- Analyst Decision
- PTGX Strong Buy
- IRT Buy
- Analyst Count
- PTGX 9
- IRT 7
- Target Price
- PTGX $86.44
- IRT $21.86
- AVG Volume (30 Days)
- PTGX 938.5K
- IRT 3.2M
- Earning Date
- PTGX 11-06-2025
- IRT 10-29-2025
- Dividend Yield
- PTGX N/A
- IRT 4.15%
- EPS Growth
- PTGX N/A
- IRT N/A
- EPS
- PTGX 0.72
- IRT 0.09
- Revenue
- PTGX $209,217,000.00
- IRT $662,924,000.00
- Revenue This Year
- PTGX N/A
- IRT $4.19
- Revenue Next Year
- PTGX $140.23
- IRT $4.72
- P/E Ratio
- PTGX $117.81
- IRT $179.97
- Revenue Growth
- PTGX N/A
- IRT 3.70
- 52 Week Low
- PTGX $33.31
- IRT $15.07
- 52 Week High
- PTGX $93.25
- IRT $22.26
- Technical
- Relative Strength Index (RSI)
- PTGX 66.14
- IRT 57.12
- Support Level
- PTGX $76.70
- IRT $15.99
- Resistance Level
- PTGX $86.90
- IRT $16.72
- Average True Range (ATR)
- PTGX 3.20
- IRT 0.38
- MACD
- PTGX 0.30
- IRT 0.10
- Stochastic Oscillator
- PTGX 83.58
- IRT 96.07
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.